ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 305799 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 305799; 2) Community: the network communities that were significantly associated with the response to NSC 305799; 3) Molecule: the relationships between components within communities and NSC 305799; 4) MDR: the compounds that were significantly associated with the NSC 305799.

NSC Compound Enrichment Correlation
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0115521552688258 0.22859604
NSC 761834 (Z)-5-chloro-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.0115521552688258 0.46118168
NSC 107124 Camptothecin Derivative 0.0140755620492158 0.40941757
NSC 264880 Dihydro-5-azacytidine 0.0140755620492158 0.16686898
NSC 268993 Deferoxamine hydrochloride 0.0140755620492158 0.46801195
NSC 409304 Null 0.0140755620492158 0.33677535
NSC 661229 Null 0.0140755620492158 -0.066494063
NSC 671165 Null 0.0140755620492158 0.31125137
NSC 67239 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-, triacetate 0.0140755620492158 0.53499005
NSC 683252 Null 0.0140755620492158 0.52201037
Total:54  Current:15    [First] [Prev] [Next] [Last]